Validus Holdings, Ltd. (VR) President Kean Driscoll Sells 6,875 Shares

Validus Holdings, Ltd. (NYSE:VR) President Kean Driscoll sold 6,875 shares of the stock in a transaction on Tuesday, January 16th. The stock was sold at an average price of $46.78, for a total value of $321,612.50. Following the sale, the president now directly owns 103,983 shares in the company, valued at $4,864,324.74. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Kean Driscoll also recently made the following trade(s):

  • On Friday, December 15th, Kean Driscoll sold 6,875 shares of Validus stock. The stock was sold at an average price of $46.16, for a total value of $317,350.00.
  • On Wednesday, November 15th, Kean Driscoll sold 6,875 shares of Validus stock. The stock was sold at an average price of $50.30, for a total value of $345,812.50.

Validus Holdings, Ltd. (NYSE:VR) traded up $0.46 during trading hours on Wednesday, reaching $47.28. The company had a trading volume of 446,655 shares, compared to its average volume of 728,156. The firm has a market capitalization of $3,760.00, a price-to-earnings ratio of -72.74, a PEG ratio of 1.25 and a beta of 0.67. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 0.52. Validus Holdings, Ltd. has a fifty-two week low of $41.15 and a fifty-two week high of $58.76.

Validus (NYSE:VR) last released its quarterly earnings data on Thursday, October 26th. The insurance provider reported ($3.22) earnings per share for the quarter, beating the consensus estimate of ($3.30) by $0.08. The business had revenue of $407.00 million for the quarter, compared to analyst estimates of $453.04 million. Validus had a negative return on equity of 0.49% and a negative net margin of 1.38%. Validus’s revenue was up 24.3% compared to the same quarter last year. During the same period last year, the firm posted $1.02 earnings per share. sell-side analysts anticipate that Validus Holdings, Ltd. will post -0.3 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 3.21%. The ex-dividend date was Thursday, December 14th. Validus’s payout ratio is -233.85%.

Hedge funds have recently made changes to their positions in the company. SG Americas Securities LLC acquired a new stake in shares of Validus during the second quarter valued at about $116,000. Zions Bancorporation acquired a new stake in shares of Validus during the third quarter valued at about $116,000. The Manufacturers Life Insurance Company boosted its stake in shares of Validus by 10.1% during the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after purchasing an additional 219 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Validus by 93.7% during the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock valued at $138,000 after purchasing an additional 1,282 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Validus by 10.6% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,905 shares of the insurance provider’s stock valued at $151,000 after purchasing an additional 278 shares in the last quarter. 96.25% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have recently issued reports on the company. Zacks Investment Research lowered Validus from a “hold” rating to a “sell” rating in a report on Saturday. Barclays reaffirmed a “hold” rating and issued a $50.00 price objective on shares of Validus in a research note on Tuesday, January 9th. Keefe, Bruyette & Woods raised Validus from a “market perform” rating to an “outperform” rating in a research note on Thursday, January 4th. UBS Group raised their price objective on Validus from $48.00 to $52.00 and gave the company a “neutral” rating in a research note on Monday, October 30th. Finally, Bank of America raised Validus from a “neutral” rating to a “buy” rating in a research note on Monday, October 30th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $54.33.

COPYRIGHT VIOLATION NOTICE: “Validus Holdings, Ltd. (VR) President Kean Driscoll Sells 6,875 Shares” was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/17/validus-holdings-ltd-vr-president-kean-driscoll-sells-6875-shares.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

Insider Buying and Selling by Quarter for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply